Viveve Company

Viveve designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal laxity. The company offers Geneveve, a non-invasive solution that includes the Viveve System, a radio frequency generator; a reusable hand piece and single-use treatment tip; and other consumable accessories. The Geneveve is indicated for use in general procedures for electrocoagulation and hemostasis in the US. The firm markets its products through sales employees and distributors in Asia, Europe, the Middle East, Latin America, the United States, Canada, and internationally.
Industry: Pelvic & Uterine Healthcare
Headquarters: Englewood, Colorado, United States
Founded Date: 01-01-2005
Employees Number: 51-100
Funding Status: M&A
Investors Number: 6
Total Funding: $167,611,369
Estimated Revenue: $1M to $10M
Last Funding Date: 2018-12-06
Last Funding Type: Post-IPO Equity

Visit Website
admin@amatoandpartners.com
https://twitter.com/vivevemedical
Register and Claim Ownership